149 related articles for article (PubMed ID: 24741328)
1. Potential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.
Oshikoya KA; Oreagba IA; Lawal S; Awodele O; Ogunleye OO; Senbanjo IO; Olayemi SO; Ezeaka VC; Temiye EO; Adeyemo TA; Opanuga O; Lesi OA; Akanmu SA
HIV AIDS (Auckl); 2014; 6():49-59. PubMed ID: 24741328
[TBL] [Abstract][Full Text] [Related]
2. Clinically Significant Drug-Drug Interaction in a Large Antiretroviral Treatment Centre in Lagos, Nigeria.
Oreagba IA; Usman SO; Oshikoya KA; Akinyede A; Agbaje E; Opanuga O; Akanmu S
J Popul Ther Clin Pharmacol; 2019 Jan; 26(1):e1-e19. PubMed ID: 31002484
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant interactions between antiretroviral and co-prescribed drugs for HIV-infected children: profiling and comparison of two drug databases.
Oshikoya KA; Oreagba IA; Ogunleye OO; Lawal S; Senbanjo IO
Ther Clin Risk Manag; 2013; 9():215-21. PubMed ID: 23700368
[TBL] [Abstract][Full Text] [Related]
4. Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.
Priyanka PSSL; Varma DM; Immadisetti K; Rajesh R; Vidyasagar S; Guddattu V
Int J Risk Saf Med; 2017; 29(1-2):25-55. PubMed ID: 28885219
[TBL] [Abstract][Full Text] [Related]
5. Clinically significant drug interactions between antiretroviral and co-prescribed drugs in HIV infected patients: retrospective cohort study.
Al Sayed HAH; Sharif-Askari NS; Rahimi MR
Med Pharm Rep; 2022 Jul; 95(3):260-266. PubMed ID: 36060510
[TBL] [Abstract][Full Text] [Related]
6. Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy.
Yiu P; Nguyen NN; Holodniy M
Pharmacotherapy; 2011 May; 31(5):480-9. PubMed ID: 21923429
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk factors for clinically significant drug interactions with antiretroviral therapy.
Miller CD; El-Kholi R; Faragon JJ; Lodise TP
Pharmacotherapy; 2007 Oct; 27(10):1379-86. PubMed ID: 17896893
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach.
Iniesta-Navalón C; Franco-Miguel JJ; Gascón-Cánovas JJ; Rentero-Redondo L
HIV Med; 2015 May; 16(5):273-9. PubMed ID: 25523089
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort.
Kigen G; Kimaiyo S; Nyandiko W; Faragher B; Sang E; Jakait B; Owen A; Back D; Gibbons S; Seden K; Khoo SH;
PLoS One; 2011 Feb; 6(2):e16800. PubMed ID: 21373194
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoepidemiology of antiretroviral drugs in a teaching hospital in Lagos, Nigeria.
Oreagba IA; Usman SO; Olayemi SO; Oshikoya KA; Opanuga O; Adeyemo TA; Lesi OA; Dodoo AN; Akanmu AS
Ghana Med J; 2014 Dec; 48(4):194-203. PubMed ID: 25709134
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
[TBL] [Abstract][Full Text] [Related]
12. High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.
Busari AA; Oreagba IA; Oshikoya KA; Kayode MO; Olayemi SO
Niger Med J; 2019; 60(6):317-325. PubMed ID: 32180663
[TBL] [Abstract][Full Text] [Related]
13. Use of complementary medicine amongst patients on antiretroviral drugs in an HIV treatment centre in Lagos, Nigeria.
Awodele O; Olayemi SO; Adeyemo TA; Sanya TA; Dolapo DC
Curr Drug Saf; 2012 Apr; 7(2):120-5. PubMed ID: 22873496
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anaemia in HIV-infected children at the University of Abuja Teaching Hospital, Gwagwalada.
Okechukwu AA; Gambo D; Okechukwu IO
Niger J Med; 2010; 19(1):50-7. PubMed ID: 20232757
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
Tourret J; Tostivint I; Tézenas Du Montcel S; Karie S; Launay-Vacher V; Vigneau C; Bessette C; Deray G; Bagnis CI
Clin Infect Dis; 2007 Sep; 45(6):779-84. PubMed ID: 17712764
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
Popoola TD; Awodele O; Oshikoya KA
Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic interaction of vicriviroc with other antiretroviral agents: results from a series of fixed-sequence and parallel-group clinical trials.
Kasserra C; O'Mara E
Clin Pharmacokinet; 2011 Apr; 50(4):267-80. PubMed ID: 21348539
[TBL] [Abstract][Full Text] [Related]
18. [Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].
Cervero M; Torres R; Jusdado JJ; Pastor S; Agud JL
Med Clin (Barc); 2016 Apr; 146(8):339-45. PubMed ID: 26971988
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentrations of efavirenz and nevirapine among HIV-infected patients with immunological failure attending a tertiary hospital in North-western Tanzania.
Gunda DW; Kasang C; Kidenya BR; Kabangila R; Mshana SE; Kidola J; Kalluvya SE; Kongola GW; Klinker H
PLoS One; 2013; 8(9):e75118. PubMed ID: 24058655
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking among healthcare professional students of University of Lagos and Lagos University Teaching Hospital (LUTH), Idi-Araba, Lagos, Nigeria.
Aina BA; Oyerinde OO; Joda AE; Dada OO
Nig Q J Hosp Med; 2009; 19(1):42-6. PubMed ID: 20830986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
